Making tumor necrosis factor blockers safer: a prescriber's consumptive challenge
Keane, J.; Ní Cheallaigh, C.
Journal of Rheumatology 35(7): 1238-1239
2008
ISSN/ISBN: 0315-162X PMID: 18597413 Document Number: 628182
Document emailed within 1 workday
Related Documents
Burgos-Vargas, R.én.; Rojas-Serrano, J. 2005: Predictors of response to tumor necrosis factor-alpha blockers in ankylosing spondylitis Journal of Rheumatology 32(9): 1637-1640Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
Hori, K.; Ehrke, M.J.; Mace, K.; Mihich, E. 1987: Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon Cancer Research 47(22): 5868-5874
He, S.; Huang, H. 1997: Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis Zhonghua Nei Ke Za Zhi 36(8): 526-528
Himeno, T.; Watanabe, N.; Yamauchi, N.; Maeda, M.; Tsuji, Y.; Okamoto, T.; Neda, H.; Niitsu, Y. 1990: Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor Cancer Research 50(16): 4941-4945
Kaneko, H.; Yamada, H.; Mizuno, S.; Udagawa, T.; Kazumi, Y.; Sekikawa, K.; Sugawara, I. 1999: Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice Laboratory Investigation; a Journal of Technical Methods and Pathology 79(4): 379-386
Zanetti, G.; Heumann, D.; Gérain, J.; Kohler, J.; Abbet, P.; Barras, C.; Lucas, R.; Glauser, M.P.; Baumgartner, J.D. 1992: Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide Journal of Immunology 148(6): 1890-1897
Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Ishioka, S.; Saito, T.; Hiyama, K.; Haruta, Y.; Maeda, A.; Hozawa, S.; Inamizu, T.; Yamakido, M. 1996: Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 13(2): 139-145
Doszczak, M.łg.M.; Kaszubowska, L.; Pierzchalski, A.; Bigda, J. 2002: Mechanism of transcription factor NF kappa B activation by tumor necrosis factor (TNF) Postepy Biochemii 48(1): 54-65
Watanabe, N.; Niitsu, Y.; Umeno, H.; Kuriyama, H.; Neda, H.; Yamauchi, N.; Maeda, M.; Urushizaki, I. 1988: Toxic effect of tumor necrosis factor on tumor vasculature in mice Cancer Research 48(8): 2179-2183
Goillot, E.; Combaret, V.; Ladenstein, R.; Baubet, D.; Blay, J.Y.; Philip, T.; Favrot, M.C. 1992: Tumor necrosis factor as an autocrine growth factor for neuroblastoma Cancer Research 52(11): 3194-3200
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
Beyaert, R.; Vanhaesebroeck, B.; Heyninck, K.; Boone, E.; De Valck, D.; Schulze-Osthoff, K.; Haegeman, G.; Van Roy, F.; Fiers, W. 1993: Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine Cancer Research 53(11): 2623-2630